MP-376
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for MP-376, covering 2012-03-02 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: "Safety, Tolerability and Pharmacokinetics of MP-376 Administered for 14 Days to Stable Pediatric (CF) Patients" [Phase 1]